Systemic and central amygdala injections of the mGluR2/3 agonist LY379268 attenuate the expression of incubation of sucrose craving in rats

Jamie L. Uejima, Jennifer M. Bossert, Gabriela C. Poles, Lin Lu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

We previously reported that systemic or central amygdala injections of the mGluR2/3 agonist LY379268 (which decreases glutamate release) prevented enhanced cue-induced cocaine seeking in extinction tests after prolonged withdrawal (incubation of cocaine craving). Here, we report that systemic and central amygdala injections of LY379268 also prevented the enhanced cue-induced sucrose seeking in extinction tests after prolonged sucrose-free period (incubation of sucrose craving). These findings suggest that central amygdala glutamate plays an important role in the incubation of reward craving after withdrawal from both drug and non-drug rewards.

Original languageEnglish (US)
Pages (from-to)292-296
Number of pages5
JournalBehavioural Brain Research
Volume181
Issue number2
DOIs
StatePublished - Aug 6 2007

Funding

This research was supported by funds from the Intramural Research Program of the NIH, the National Institute on Drug Abuse to the Neurobiology of Relapse Section (PI. Yavin Shaham). We thank Eli Lilly for providing LY379268, and Dr. Yavin Shaham for his help in the preparation of this manuscript.

Keywords

  • Central amygdala
  • Food reward
  • Glutamate
  • Incubation of craving
  • Relapse
  • Sucrose

ASJC Scopus subject areas

  • Behavioral Neuroscience

Fingerprint

Dive into the research topics of 'Systemic and central amygdala injections of the mGluR2/3 agonist LY379268 attenuate the expression of incubation of sucrose craving in rats'. Together they form a unique fingerprint.

Cite this